Today: 7 February 2026
Subscribe
Browse Category

Earnings Reports News 7 January 2026

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth shares fell over 2% to $340.44 Wednesday morning, erasing part of Tuesday’s gain. The drop followed analyst moves, with Bernstein raising its target to $444 and Evercore ISI starting coverage at $400. Investors await UnitedHealth’s Jan. 27 results and Medicare Advantage rate updates. Humana and Cigna also declined.
7 January 2026
·······
Applied Digital stock edges up ahead of earnings as new analyst targets reach $99

Applied Digital stock edges up ahead of earnings as new analyst targets reach $99

Applied Digital shares rose about 2% Wednesday morning ahead of quarterly results due after the bell. Freedom Capital and Arete initiated coverage with Buy ratings and price targets of $36 and $99, respectively. Investors await updates on AI data-center leasing and the planned ChronoScale cloud spin-out. Analysts expect quarterly revenue of $90.5 million and a loss of $0.11 per share.
7 January 2026
··
AT&T stock slips after fresh downgrade as traders brace for jobs data and Jan. 28 earnings

AT&T stock slips after fresh downgrade as traders brace for jobs data and Jan. 28 earnings

AT&T shares fell 1.1% to $24.06 Wednesday after Arete Research downgraded the stock to “sell” with a $20 target. The move came as the S&P 500 traded flat and investors awaited Friday’s U.S. payrolls report. AT&T is set to report fourth-quarter results on Jan. 28. American Airlines announced a new partnership with AT&T to provide free in-flight Wi-Fi for loyalty members.
7 January 2026
··
Nvidia stock climbs on China H200 demand comments as Feb. 25 earnings loom

Nvidia stock climbs on China H200 demand comments as Feb. 25 earnings loom

Nvidia shares rose 1.8% to $190.55 after CEO Jensen Huang said Chinese purchase orders, not announcements, would signal approval for H200 chip imports. Data-center cooling stocks fell following Nvidia’s comments on lower cooling needs. Traders are watching U.S. export-license timing ahead of Nvidia’s Feb. 25 results. Rival AMD dropped 1.9% after unveiling new AI chips at CES.
7 January 2026
···
Vale (VALE) stock wobbles after Tuesday surge as iron ore firms; Feb. 12 results loom

Vale (VALE) stock wobbles after Tuesday surge as iron ore firms; Feb. 12 results loom

Vale’s U.S. shares fell 0.8% to $14.05 in early Wednesday trading, while Rio Tinto and BHP dropped 1.5% and 1.8%. Brazil shipped a record 416.4 million metric tons of iron ore in 2025, up 7.1% from the previous year. Vale will pay R$1.2441 per share in dividends Jan. 7, with a second installment in March. Iron ore futures in China hit their highest since July before retreating.
7 January 2026
···
Intuitive Surgical stock jumps as investors eye JPM healthcare conference and Jan. 22 earnings

Intuitive Surgical stock jumps as investors eye JPM healthcare conference and Jan. 22 earnings

Intuitive Surgical shares closed up 4.6% at $592.85 Tuesday and gained another 0.4% after hours. Evercore ISI raised its price target to $580, citing strong procedure and capital spending trends but kept an “In Line” rating. Trading volume reached 2.63 million shares. The company will present at the J.P. Morgan Healthcare Conference on Jan. 14 and report earnings Jan. 22.
7 January 2026
··
NatWest share price drops after Barclays downgrade as buybacks and earnings come into focus

NatWest share price drops after Barclays downgrade as buybacks and earnings come into focus

NatWest shares dropped 2.7% to 642.8 pence after Barclays downgraded the stock to “equal weight.” The bank continued its £750 million buyback, purchasing 787,737 shares Tuesday. Barclays trimmed 2026-27 earnings estimates by 4% and warned rising risk-weighted assets could limit surplus capital. Investors await NatWest’s Feb. 13 results for updates on margins and capital targets.
7 January 2026
··
Tesco PLC stock dips ahead of Q3 Christmas update — what TSCO.L investors watch next

Tesco PLC stock dips ahead of Q3 Christmas update — what TSCO.L investors watch next

Tesco shares fell 0.8% to 451.5 pence early Wednesday ahead of its Q3 and Christmas sales update. Industry data showed Tesco’s market share rose to 28.7%, its highest since 2015, as sales grew 4.3% in the 12 weeks to Dec. 28. The company continued its share buyback, purchasing 454,043 shares on Jan. 5. Investors remain alert to margin risks from holiday discounting.
7 January 2026
··
Haleon PLC stock edges lower after executive share-deal filing, with earnings in focus

Haleon PLC stock edges lower after executive share-deal filing, with earnings in focus

London, January 7, 2026, 09:04 GMT — Regular session Haleon shares edged lower in early London trade on Wednesday after the consumer healthcare group disclosed small share acquisitions by two senior executives under its reward plan. The stock was down 0.4% at 375.2 pence by 0839 GMT, having risen about 1.1% in the previous session. It traded between 374.1 and 378.0 pence, within a 52-week range of 325.1 to 419.4 pence, valuing the company at about £33.4 billion. Share Prices The disclosure lands at the start of the year, when investors tend to scan regulatory filings for fresh signals on
7 January 2026
··
RELX share price rises in London after buyback update as investors eye Feb. 12 results

RELX share price rises in London after buyback update as investors eye Feb. 12 results

London, Jan 7, 2026, 08:48 GMT — Regular session Shares in RELX (REL.L) rose 0.8% to 3,103 pence in early London trade on Wednesday after the company disclosed another round of share repurchases. The stock ranged between 3,089 and 3,117 pence and remains about a quarter below its 52-week high of 4,205 pence. Google The steady drumbeat of buybacks has given traders a near-term anchor as they look past day-to-day swings and toward the next set of company numbers. RELX has been a defensive holding for many UK investors, prized for subscription-style revenue from legal, risk and scientific information services.
7 January 2026
···
Unilever shares slip in early London trade — what investors watch before Feb 12 results

Unilever shares slip in early London trade — what investors watch before Feb 12 results

London, Jan 7, 2026, 08:55 GMT — Regular session Unilever PLC shares fell 0.9% to 4,703.5 pence by 08:28 GMT, leaving them down about 2.5% since Jan. 2. The stock traded between 4,698 and 4,750 pence and is about 5% below its 52-week high of 4,930 pence. Share Prices The move came as European shares paused after a string of record closes, with investors weighing U.S.-Venezuela headlines and a busy economic calendar. Oil prices fell after U.S. President Donald Trump said Washington had struck a deal to import $2 billion worth of Venezuelan crude, while Nestle slid after recalling some
7 January 2026
··
CapitaLand Investment (9CI) stock edges up as Feb 11 results date nears; DBS deck highlights fee growth

CapitaLand Investment (9CI) stock edges up as Feb 11 results date nears; DBS deck highlights fee growth

Singapore, Jan 7, 2026, 15:49 SGT — Regular session Shares of CapitaLand Investment Limited (SGX:9CI) edged up 0.36% to S$2.77 by 3:20 p.m. Singapore time on Wednesday, near the top of the day’s S$2.76-S$2.78 range and not far from a 52-week high of S$2.87. StockAnalysis The Singapore-listed real asset manager is heading into a dense stretch of investor touchpoints, when markets will test whether fee income can keep rising as managers push new funds and recycle capital. Fee-related revenue is the recurring money an asset manager earns for running clients’ assets, while funds under management measures the size of that
7 January 2026
···
Keppel Ltd stock slips in Singapore trade as rally pauses; investors eye Feb 5 results

Keppel Ltd stock slips in Singapore trade as rally pauses; investors eye Feb 5 results

Singapore, Jan 7, 2026, 15:28 SGT — Regular session Keppel Ltd shares fell 1.7% to S$10.48 by 3:19 p.m. in Singapore, snapping a two-session rise that ended at S$10.66 on Tuesday. SG Investors The pullback comes as Singapore’s Straits Times Index (STI) sits near record highs, driven by a rally in bank shares that has pushed the benchmark to fresh peaks this week. Morningstar’s Lorraine Tan said investors are treating dividend-paying stocks as a “proxy to holding Singapore government bonds” as they brace for lower rates. The Straits Times Strategists have also flagged Keppel as a beneficiary of the market’s
7 January 2026
···
OCBC stock dips from record highs as Singapore bank rally pauses; Feb 25 results loom

OCBC stock dips from record highs as Singapore bank rally pauses; Feb 25 results loom

Singapore, Jan 7, 2026, 15:17 SGT — Regular session Shares of Oversea-Chinese Banking Corp (OCBC) (SGX:O39) fell 0.6% on Wednesday as traders took profit after the stock moved above S$20. By 2:59 p.m. Singapore time, OCBC was at S$20.06 after earlier trading as high as about S$20.25; peer DBS Group (D05) rose 0.6% and United Overseas Bank (U11) slipped 0.1%. Google The pullback keeps OCBC in focus after it crossed the S$20 mark for the first time on Tuesday, when Singapore’s benchmark Straits Times Index (STI) broke 4,700 points. The index hit an all-time high of 4,741.85 points in late
7 January 2026
···
1 … 108 109 110 111 112 … 202

Stock Market Today

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
Go toTop